AU Patent

AU4692399A — Cyclic hydroxamic acids as metalloproteinase inhibitors

Assigned to Bristol Myers Squibb Pharma Co · Expires 2000-01-05 · 26y expired

What this patent protects

Patent listed against Tavneos.

Drugs covered by this patent

Patent Metadata

Patent number
AU4692399A
Jurisdiction
AU
Classification
—
Expires
2000-01-05
Drug substance claim
No
Drug product claim
No
Assignee
Bristol Myers Squibb Pharma Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.